Francis Dodeller

Title: The Innovations of Francis Dodeller

Introduction

Francis Dodeller is a notable inventor based in Gilching, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting M-CSF. With a total of 2 patents to his name, Dodeller's work has the potential to impact the treatment of various diseases.

Latest Patents

Dodeller's latest patents focus on antibodies or antibody fragments that specifically bind to M-CSF. These antibodies are designed to inhibit the binding of M-CSF to its receptor with an IC50 of 10 pM or less. The inventions also encompass nucleic acids, vectors, and host cells capable of expressing these antibodies or fragments. Furthermore, pharmaceutical compositions containing these antibodies are developed for the treatment of specific diseases.

Career Highlights

Francis Dodeller is currently associated with Morphosys AG, a company known for its innovative approaches in the field of biopharmaceuticals. His work at Morphosys AG has allowed him to explore and develop groundbreaking solutions in antibody technology.

Collaborations

Dodeller collaborates with Robert Rauchenberger, contributing to the advancement of their shared goals in biotechnology and innovation.

Conclusion

Francis Dodeller's contributions to the field of biotechnology through his patents and work at Morphosys AG highlight his role as an influential inventor. His focus on antibodies targeting M-CSF showcases the potential for significant advancements in medical treatments.